Pinnacle Biologics Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$45M
Pinnacle Biologics General Information
Description
Developer of bio-pharmaceutical drugs. The company develops therapies for oncology and other diseases.
Contact Information
Website
www.pinnaclebiologics.comCorporate Office
- 2801 Lakeside Drive
- Suite 209
- Deerfield, IL 60015
- United States
Corporate Office
- 2801 Lakeside Drive
- Suite 209
- Deerfield, IL 60015
- United States
Pinnacle Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 24-Dec-2013 | $45M | Completed | Profitable | ||
| 3. Later Stage VC | 20-Dec-2012 | Completed | Profitable | |||
| 2. Early Stage VC (Series A) | 29-Dec-2011 | $1.5M | $1.63M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC (Series A) | 10-Jun-2008 | $132K | $132K | Completed | Product Development |
Pinnacle Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Pinnacle Biologics Patents
Pinnacle Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022316132-A1 | Photodynamic therapy compositions and methods of treatment therein | Pending | 20-Jul-2021 | ||
| CA-3226378-A1 | Photodynamic therapy compositions and methods of treatment therein | Pending | 20-Jul-2021 | ||
| EP-4373524-A1 | Photodynamic therapy compositions and methods of treatment therein | Inactive | 20-Jul-2021 | ||
| US-20220354953-A1 | Photodynamic therapy compositions and methods of treatment therein | Pending | 20-Jul-2021 | ||
| WO-2023003960-A1 | Photodynamic therapy compositions and methods of treatment therein | Inactive | 20-Jul-2021 | A61K41/0071 |
Pinnacle Biologics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Esperante Ventures | Corporate Venture Capital | Minority | ||
| Numoda Capital Innovations | Venture Capital | Minority |
Pinnacle Biologics Investments (1)
Pinnacle Biologics’s most recent deal was a Corporate Asset Purchase with Axcan (Photofrin and Photobarr). The deal was made on 29-Mar-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Axcan (Photofrin and Photobarr) | 29-Mar-2011 | Corporate Asset Purchase | Buildings and Property |
Pinnacle Biologics FAQs
-
When was Pinnacle Biologics founded?
Pinnacle Biologics was founded in 2007.
-
Where is Pinnacle Biologics headquartered?
Pinnacle Biologics is headquartered in Deerfield, IL.
-
What industry is Pinnacle Biologics in?
Pinnacle Biologics’s primary industry is Pharmaceuticals.
-
Is Pinnacle Biologics a private or public company?
Pinnacle Biologics is a Private company.
-
What is the current valuation of Pinnacle Biologics?
The current valuation of Pinnacle Biologics is .
-
What is Pinnacle Biologics’s current revenue?
The current revenue for Pinnacle Biologics is .
-
How much funding has Pinnacle Biologics raised over time?
Pinnacle Biologics has raised $1.63M.
-
Who are Pinnacle Biologics’s investors?
Esperante Ventures and Numoda Capital Innovations have invested in Pinnacle Biologics.
-
When was Pinnacle Biologics acquired?
Pinnacle Biologics was acquired on 24-Dec-2013.
-
Who acquired Pinnacle Biologics?
Pinnacle Biologics was acquired by Advanz Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process